Patient-specific respiratory motion management using lung tumors vs fiducial markers for real-time tumor-tracking stereotactic body radiotherapy.

Abstract

In real-time lung tumor-tracking stereotactic body radiotherapy (SBRT), tracking accuracy is related to radiotherapy efficacy. This study aimed to evaluate the respiratory movement relationship between a lung tumor and a fiducial marker position in each direction using four-dimensional (4D) computed tomography (CT) images. A series of 31 patients with a fiducial marker for lung SBRT was retrospectively analyzed using 4DCT. In the upper (UG) and middle and lower lobe groups (MLG), the cross-correlation coefficients of respiratory movement between the lung tumor and fiducial marker position in four directions (anterior-posterior, left-right, superior-inferior [SI], and three-dimensional [3D]) were calculated for each gating window (≤1, ≤2, and≤3mm). Subsequently, the proportions of phase numbers in unplanned irradiation (with lung tumors outside the gating window and fiducial markers inside the gating window) were calculated for each gating window. In the SI and 3D directions, the cross-correlation coefficients were significantly different between UG (mean r=0.59, 0.63, respectively) and MLG (mean r=0.95, 0.97, respectively). In both the groups, the proportions of phase numbers in unplanned irradiation were 11%, 28%, and 63% for the≤1-, ≤2-, and≤3-mm gating windows, respectively. Compared with MLG, fiducial markers for UG have low cross-correlation coefficients between the lung tumor and the fiducial marker position. Using 4DCT to assess the risk of unplanned irradiation in a gating window setting and selecting a high cross-correlation coefficient fiducial marker in advance are important for accurate treatment using lung SBRT.